Clearing the complexity: immune complexes and their treatment in lupus nephritis. - Wikidata - awgldk - TriplyDB

Clearing the complexity: immune complexes and their treatment in lupus nephritis.

Clearing the complexity: immune complexes and their treatment in lupus nephritis.

http://www.wikidata.org/entity/Q37892917

about

Human CD4(+) T-Cells: A Role for Low-Affinity Fc Receptors Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura.New Treatments for Systemic Lupus Erythematosus on the Horizon: Targeting Plasmacytoid Dendritic Cells to Inhibit Cytokine Production.

P2860

Q26745538-0F10BE56-B545-4283-A9F9-761352B76940 Q33411525-41D41BB9-FAE5-4279-B647-7CBE5D04A264 Q49499785-5741D941-C19E-4356-AA8F-D59FDDBD1539

P2860

Clearing the complexity: immune complexes and their treatment in lupus nephritis.

http://www.wikidata.org/entity/Q37892917

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 January 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clearing the complexity: immune complexes and their treatment in lupus nephritis.

@en

Clearing the complexity: immune complexes and their treatment in lupus nephritis.

@nl

type

label

Clearing the complexity: immune complexes and their treatment in lupus nephritis.

@en

Clearing the complexity: immune complexes and their treatment in lupus nephritis.

@nl

prefLabel

Clearing the complexity: immune complexes and their treatment in lupus nephritis.

@en

Clearing the complexity: immune complexes and their treatment in lupus nephritis.

@nl

P1433

Q37892917-710BB0EC-D299-4EA3-B8EF-1F75DF23EA6B

P1476

Q37892917-EE8061DB-93C1-4734-B65E-60DCF57464D0

P2093

Q37892917-44C30572-B568-425E-B454-CF54BB74EE48

Q37892917-D01F1132-1676-491A-BB3A-3F91F6FA18DC

Q37892917-E367E38C-3E95-4EA9-8BBD-5A502834F8CA

P2860

Q37892917-003EEDBA-1ED3-4F73-8E32-791B3A91BC9E

Q37892917-01C830BA-4BFC-4948-980A-F91ECACCE234

Q37892917-051B2ABB-2C24-4CF9-AF16-D934740077E4

Q37892917-0AB7705F-D4E1-4B03-98CD-A2BD6CFF6859

Q37892917-116DE647-2F45-4EB7-90E6-89B9C6727AE4

Q37892917-18BF5ADC-8FFF-431E-8239-1694CC889746

Q37892917-1B8FBFBA-0730-4CB1-963B-2060857DFE07

Q37892917-1BB98F6E-B0B9-4C48-90A3-73056C8010A0

Q37892917-1D916813-C225-4ABD-85F7-09C7FCCE8E5D

Q37892917-223D9CE4-5FD9-48A4-89BA-0CE084A86B33

P304

Q37892917-38F8BDA3-DB61-4A62-91BF-B6B26BCA49DC

P31

Q37892917-5B0F0D19-2D97-4AD7-8003-F7E5979D3BCB

P356

Q37892917-60F712AE-6F27-4FF8-B65F-5446B6EF3F2D

P407

Q37892917-A54B5E18-75AD-4888-9E33-5514622FC87A

P478

Q37892917-5B0EF3C6-05A7-493E-A57F-3294DB99AEA5

P577

Q37892917-B682C87C-32AC-4508-B960-28122E21D2F9

P5875

Q37892917-463D03D3-58BA-4A6E-AD13-F51811316C17

P698

Q37892917-50802775-03F2-4BC2-B4DF-B8D5A7347FAA

P932

Q37892917-2CE43E28-401D-4036-BD9E-9C84D4B9768B

P356

P1433

International Journal of Nephrology and Renovascular Disease

P1476

Clearing the complexity: immune complexes and their treatment in lupus nephritis.

@en

P2093

Catherine Toong

http://www.w3.org/2001/XMLSchema#string

Stephen Adelstein

http://www.w3.org/2001/XMLSchema#string

Tri Giang Phan

http://www.w3.org/2001/XMLSchema#string

P2860

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus

Basophils and nephritis in lupus

Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry.

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.

Use of rituximab in the treatment of refractory systemic lupus erythematosus: Singapore experience.

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.

B cell-targeted therapies for systemic lupus erythematosus: an update on clinical trial data.

Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohorts.

Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study.

P304

17-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJNRD.S10233

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51240109

http://www.w3.org/2001/XMLSchema#string

P698

21694945

http://www.w3.org/2001/XMLSchema#string

P932

3108794

http://www.w3.org/2001/XMLSchema#string